Barclays
KEQU icon

Barclays’s Kewaunee Scientific KEQU Stock Holding History

Barclays’s Portfolio KEQU Stock Details KEQU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$73.2K Sell
2,137
-320
-13% -$12.4K ﹤0.01% 4160
2025
Q4 		$91.9K Buy
+2,457
New +$99.9K ﹤0.01% 4604
2025
Q2 		– Sell
-101
Closed -$3.98K – 5410
2025
Q1 		$3.98K Sell
101
-2,152
-96% -$120K ﹤0.01% 4950
2024
Q4 		$139K Sell
2,253
-1,368
-38% -$55.7K ﹤0.01% 4486
2024
Q3 		$121K Buy
+3,621
New +$170K ﹤0.01% 4520
2020
Q1 		– Sell
-1
Closed – – 6310
2019
Q4 		$0 Sell
1
-4
-80% -$63 ﹤0.01% 6581
2019
Q3 		$0 Buy
+5
New +$84 ﹤0.01% 6921

Other funds holding KEQU

Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DLP
De Lisle Partners Poole, United Kingdom $836M AUM 58.41% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barclays's KEQU Position: Q1 2026 in Review

Barclays reduced its Kewaunee Scientific (KEQU) stake by 13% in Q1 2026, selling an estimated $12.4K and leaving 2,137 shares worth $73.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4160.

Barclays first reported a position in KEQU in Q3 2019 and has held it in 7 quarters since. The position peaked at $139K in Q4 2024. 32 funds tracked by Wall St. Rank hold KEQU as of Q1 2026.

  • Barclays held 2,137 shares of Kewaunee Scientific worth $73.2K as of Q1 2026.
  • Barclays sold 320 Kewaunee Scientific shares in Q1 2026, an estimated $12.4K.
  • Kewaunee Scientific made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4160 holding.
  • Barclays first reported a position in Kewaunee Scientific in Q3 2019 and has held it in 7 quarters since.
  • Barclays's Kewaunee Scientific position peaked at $139K in Q4 2024.
  • 32 funds tracked by Wall St. Rank held Kewaunee Scientific as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.